Table 1.
Results of the confirmation panel with the Aptima® HPV assay.
| Sample | Aptima hrHPV positive | Aptima hrHPV negative |
|---|---|---|
| hrHPV-positive PAP1 (n = 20) | 14 (70%) | 6 (30%) |
| hrHPV-positive PAP2 (n = 10) | 10 (100%) | 0 (0%) |
| hrHPV-positive PAP3A (n = 10) | 9 (90%) | 1 (10%) |
| hrHPV-positive PAP3B (n = 10) | 10 (100%) | 0 (0%) |
| hrHPV-negative (n = 5) | 0 (0%) | 5 (100%) |
Samples were previously tested by the Cobas® HPV assay. The panel consisted of n = 20 hrHPV-positive PAP1, n = 10 hrHPV-positive PAP2, n = 10 hrHPV-positive PAP3A, n = 10 hrHPV-positive PAP3B, and n = 5 hrHPV-negative cervical smears.